Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Patent Number 11400087
US 11400087 B2Filled DateJun 23, 2021
Priority DateSep 24, 2013
Publication DateOct 7, 2021
Expiration DateSep 23, 2033
Inventor/ApplicantsArash Raoufinia
ExaminesKOSTURKO, GEORGE W
Art Unit1628
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramSee the invalidated claims, subscribe to our Concierge Program.
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.